AAM
CLBT icon

Advisors Asset Management’s Cellebrite CLBT Stock Holding History

Advisors Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
20,007
+4,673
+30% +$61.8K ﹤0.01% 1090
2026
Q1 		$211K Buy
15,334
+5,389
+54% +$81.2K ﹤0.01% 1135
2025
Q4 		$179K Buy
9,945
+4,388
+79% +$78.8K ﹤0.01% 1144
2025
Q3 		$103K Sell
5,557
-1,294
-19% -$20.3K ﹤0.01% 1209
2025
Q2 		$110K Buy
6,851
+718
+12% +$12.8K ﹤0.01% 1192
2025
Q1 		$119K Buy
6,133
+1,214
+25% +$25.6K ﹤0.01% 1167
2024
Q4 		$108K Buy
4,919
+1,842
+60% +$35.5K ﹤0.01% 1213
2024
Q3 		$51.8K Buy
3,077
+1,742
+130% +$25.8K ﹤0.01% 1303
2024
Q2 		$16K Buy
+1,335
New +$14.9K ﹤0.01% 1388

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Advisors Asset Management's CLBT Position: Q2 2026 in Review

Advisors Asset Management increased its Cellebrite (CLBT) stake by 30% in Q2 2026, buying an estimated $61.8K and bringing the position to 20,007 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Advisors Asset Management first reported a position in CLBT in Q2 2024 and has held it in 9 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Advisors Asset Management held 20,007 shares of Cellebrite worth $292K as of Q2 2026.
  • Advisors Asset Management bought 4,673 Cellebrite shares in Q2 2026, an estimated $61.8K.
  • Cellebrite made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1090 holding.
  • Advisors Asset Management first reported a position in Cellebrite in Q2 2024 and has held it in 9 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.